Abstract
Skin cancer is the most common form of cancer, accounting for 40–50% of all cancers diagnosed in the United States (Sample and He, Photodermatol Photoimmunol Photomed 34:13–24, 2017) and the incidence continues to increase worldwide. In 2012, the estimated occurrence for nonmelanoma skin cancers (NMSC) was 5.4 million cases among 3.3 million people and the American Cancer Society estimates that 99,550 cases of other skin cancer, primarily melanoma, will occur in 2018 leading to 9320 deaths from melanoma (2018). While the incidence of the majority of cancers is currently declining, the epidemic of skin cancer continues (Lazovich et al., Cancer Epidemiol Biomark Prev 21:1893–1901, 2012). With the continuing rise in incidence, there is an extensive impact of morbidity and health care costs. The estimated annual health care cost for treating skin cancer exceeds $8.1 billion demonstrating a 126% rise in cost from 2006 to 2011 while other cancers increased by 25.1% (Jemal et al., J Am Acad Dermatol 65:S17–25.e11–13, 2011; Guy et al., Am J Prev Med 48:183–187, 2015).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abe Y, Matsumoto S, Kito K, Ueda N (2000) Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J Biol Chem 275(28):21525–21531
Abe Y, Takeuchi T, Kagawa-Miki L, Ueda N, Shigemoto K, Yasukawa M, Kito K (2007) A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis. J Mol Biol 370(2):231–245
Adhami VM, Aziz MH, Mukhtar H, Ahmad N (2003) Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin Cancer Res 9(8):3176–3182
Afaq F, Adhami VM, Mukhtar H (2005) Photochemoprevention of ultraviolet B signaling and photocarcinogenesis. Mutat Res 571(1–2):153–173
Agarwala SS, di Pietro A, Flaherty KT, Garbe C, Grob JJ, Kashani-Sabet M, Kirkwood JM, Leachman S, Messina J, O’Day S, Ribas A, Sondak V (2010) Meeting report from the Third Global Workshop on Melanoma. Pigment Cell Melanoma Res 23(5):e1–e7
Ahsan H, Reagan-Shaw S, Eggert DM, Tan TC, Afaq F, Mukhtar H, Ahmad N (2007) Protective effect of sanguinarine on ultraviolet B-mediated damages in SKH-1 hairless mouse skin: implications for prevention of skin cancer. Photochem Photobiol 83(4):986–993
Albanell J, Rojo F, Averbuch S, Feyereislova A, Mascaro JM, Herbst R, LoRusso P, Rischin D, Sauleda S, Gee J, Nicholson RI, Baselga J (2002) Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J Clin Oncol 20(1):110–124
Alberts DS, Dorr RT, Einspahr JG, Aickin M, Saboda K, Xu MJ, Peng YM, Goldman R, Foote JA, Warneke JA, Salasche S, Roe DJ, Bowden GT (2000) Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol Biomark Prev 9(12):1281–1286
Alberts D, Ranger-Moore J, Einspahr J, Saboda K, Bozzo P, Liu Y, Xu XC, Lotan R, Warneke J, Salasche S, Stratton S, Levine N, Goldman R, Islas M, Duckett L, Thompson D, Bartels P, Foote J (2004) Safety and efficacy of dose-intensive oral vitamin A in subjects with sun-damaged skin.[Erratum appears in Clin Cancer Res. 2004 Aug 15;10(16):5640]. Clin Cancer Res 10(6):1875–1880
Almahroos M, Kurban AK (2004) Ultraviolet carcinogenesis in nonmelanoma skin cancer. Part I: incidence rates in relation to geographic locations and in migrant populations. Skinmed 3(1):29–35; quiz 35-26
Altieri DC (2001) The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7(12):542–547
Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3(1):46–54
Altieri DC, Marchisio PC (1999) Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Investig 79(11):1327–1333
An KP, Athar M, Tang X, Katiyar SK, Russo J, Beech J, Aszterbaum M, Kopelovich L, Epstein EH Jr, Mukhtar H, Bickers DR (2002) Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem Photobiol 76(1):73–80
Angel P, Hattori K, Smeal T, Karin M (1988) The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55(5):875–885
Ascenso A, Pedrosa T, Pinho S, Pinho F, de Oliveira JM, Cabral Marques H, Oliveira H, Simoes S, Santos C (2016) The effect of lycopene preexposure on UV-B-irradiated human keratinocytes. Oxidative Med Cell Longev 2016:8214631
Asgari MM, Brasky TM, White E (2012) Association of vitamin A and carotenoid intake with melanoma risk in a large prospective cohort. J Investig Dermatol 132(6):1573–1582
Aszterbaum M, Rothman A (1998) Identification of mutation in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol 110(6):885–888
Auger KR, Serunian LA, Soltoff SP, Libby P, Cantley LC (1989) PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57(1):167–175
Ayllon V, O’Connor R (2007) PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response. Oncogene 26(24):3451–3461
Aziz MH, Kumar R, Ahmad N (2003) Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 23(1):17–28
Aziz MH, Reagan-Shaw S, Wu J, Longley BJ, Ahmad N (2005) Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?.[Erratum appears in FASEB J. 2005 Jul;19(9):1 p following 1195]. FASEB J 19(9):1193–1195
Bachelor MA, Bowden GT (2004a) Ultraviolet A-induced modulation of Bcl-XL by p38 MAPK in human keratinocytes: post-transcriptional regulation through the 3′-untranslated region. J Biol Chem 279(41):42658–42668
Bachelor MA, Bowden GT (2004b) UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression. Semin Cancer Biol 14(2):131–138
Bachelor MA, Cooper SJ, Sikorski ET, Bowden GT (2005) Inhibition of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase decreases UVB-induced activator protein-1 and cyclooxygenase-2 in a SKH-1 hairless mouse model. Mol Cancer Res 3(2):90–99
Bair WB 3rd, Hart N, Einspahr J, Liu G, Dong Z, Alberts D, Bowden GT (2002) Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis. Cancer Epidemiol Biomark Prev 11(12):1645–1652
Baldi A, Santini D, Battista T, Dragonetti E, Ferranti G, Petitti T, Groeger AM, Angelini A, Rossiello R, Baldi F, Natali PG, Paggi MG (2001) Expression of AP-2 transcription factor and of its downstream target genes c-kit, E-cadherin and p21 in human cutaneous melanoma. J Cell Biochem 83(3):364–372
Bartels PH, Ranger-Moore J, Stratton MS, Bozzo P, Einspahr J, Liu Y, Thompson D, Alberts DS (2002) Statistical analysis of chemopreventive efficacy of vitamin A in sun-exposed, normal skin. Anal Quant Cytol Histol 24(4):185–197
Barthelman M, Bair WB 3rd, Stickland KK, Chen W, Timmermann BN, Valcic S, Dong Z, Bowden GT (1998a) (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis 19(12):2201–2204
Barthelman M, Chen W, Gensler HL, Huang C, Dong Z, Bowden GT (1998b) Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. Cancer Res 58(4):711–716
Barton JK, Gossage KW, Xu W, Ranger-Moore JR, Saboda K, Brooks CA, Duckett LD, Salasche SJ, Warneke JA, Alberts DS (2003) Investigating sun-damaged skin and actinic keratosis with optical coherence tomography: a pilot study. Technol Cancer Res Treat 2(6):525–535
Basset-Seguin N, Escot C, Blanchard JM, Kerai C, Verrier B, Mion H, Guilhou JJ (1990) High levels of c-fos proto-oncogene expression in normal human adult skin. J Invest Dermatol 94(4):418–422
Bastiaens MT, ter Huurne JA, Kielich C, Gruis NA, Westendorp RG, Vermeer BJ, Bavinck JN (2001) Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 68(4):884–894
Bedogni B, O’Neill MS, Welford SM, Bouley DM, Giaccia AJ, Denko NC, Powell MB (2004) Topical treatment with inhibitors of the phosphatidylinositol 3′-kinase/Akt and Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways reduces melanoma development in severe combined immunodeficient mice. Cancer Res 64(7):2552–2560
Bedogni B, Welford SM, Kwan AC, Ranger-Moore J, Saboda K, Powell MB (2006) Inhibition of phosphatidylinositol-3-kinase and mitogen-activated protein kinase kinase 1/2 prevents melanoma development and promotes melanoma regression in the transgenic TPRas mouse model. Mol Cancer Ther 5(12):3071–3077
Bennett BL, Sasaki DT, Murray BW, O’Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98(24):13681–13686
Berman B, Ricotti CA Jr, Cazzaniga A, Davis SC (2004) Determination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream. Dermatol Surg 30(5):784–786
Berton TR, Mitchell DL, Fischer SM, Locniskar MF (1997) Epidermal proliferation but not quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis. J Investig Dermatol 109(3):340–347
Bibbo M, Bartels PH, Galera-Davidson H, Dytch HE, Wied GL (1986) Markers for malignancy in the nuclear texture of histologically normal tissue from patients with thyroid tumors. Anal Quant Cytol Histol 8(2):168–176
Bibbo M, Michelassi F, Bartels PH, Dytch H, Bania C, Lerma E, Montag AG (1990) Karyometric marker features in normal-appearing glands adjacent to human colonic adenocarcinoma. Cancer Res 50(1):147–151
Birt DF, Mitchell D, Gold B, Pour P, Pinch HC (1997) Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 17(1a):85–91
Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A, Tucker MA, Melanoma Genetics C (2002) Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 94(12):894–903
Bjornhagen V, Bonfoco E, Brahme EM, Lindholm J, Auer G (1994) Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma. Am J Dermatopathol 16(6):615–623
Bode AM, Dong Z (2004) Targeting signal transduction pathways by chemopreventive agents. Muta Res 555(1-2):33–51
Bode AM, Dong Z (2011) The two faces of capsaicin. Cancer Res 71(8):2809–2814
Bordbar A, Dias D, Cabral A, Beck S, Boon ME (2007) Assessment of cell proliferation in benign, premalignant and malignant skin lesions. Appl Immunohistochem Mol Morphol 15(2):229–235
Borland R, Marks R, Noy S (1992) Public knowledge about characteristics of moles and melanomas. Aust J Public Health 16(4):370–375
Bowden GT (2004) Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat Rev Cancer 4(1):23–35
Box NF, Wyeth JR, O’Gorman LE, Martin NG, Sturm RA (1997) Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 6(11):1891–1897
Bozzo PD, Vaught LC, Alberts DS, Thompson D, Bartels PH (1998) Nuclear morphometry in solar keratosis. Anal Quant Cytol Histol 20(1):21–28
Bozzo P, Alberts DS, Vaught L, da Silva VD, Thompson D, Warnecke J, Miller RC, Einspahr J, Bartels PH (2001) Measurement of chemopreventive efficacy in skin biopsies. Anal Quant Cytol Histol 23(4):300–312
Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 88(22):10124–10128
Bregman MD, Meyskens FL Jr (1986) Difluoromethylornithine enhances inhibition of melanoma cell growth in soft agar by dexamethasone, clone A interferon and retinoic acid. Int J Cancer 37(1):101–107
Broome Powell M, Gause PR, Hyman P, Gregus J, Lluria-Prevatt M, Nagle R, Bowden GT (1999) Induction of melanoma in TPras transgenic mice. Carcinogenesis 20(9):1747–1753
Brunssen A, Waldmann A, Eisemann N, Katalinic A (2016) Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: a systematic review. J Am Acad Dermatol 76(1):129–139.e110
Buchwald H (1992) Cholesterol inhibition, cancer, and chemotherapy. Lancet 339(8802):1154–1156
Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J, Pentland AP (1998) COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 19(5):723–729
Budden T, Davey RJ, Vilain RE, Ashton KA, Braye SG, Beveridge NJ, Bowden NA (2016) Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair. Oncotarget 7(38):60940–60953
Burren R, Scaletta C, Frenk E, Panizzon RG, Applegate LA (1998) Sunlight and carcinogenesis: expression of p53 and pyrimidine dimers in human skin following UVA I, UVA I + II and solar simulating radiations. Int J Cancer 76(2):201–206
Bush JA, Cheung KJ Jr, Li G (2001) Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271(2):305–314
Callen J (2000) Statement on actinic keratosis. J Am Acad Dermatol 42(1Part 2):1
Cancer Facts & Figures 2018 (2018). http://www.cancer.org/content/dam/cancer-org/research/cancerr-facts-and-statistics-annual-cancer-facts-and-figures/2018/cancer-facts-and-figures
CDC (2012) Sunburn and sun protective behaviors among adults aged 19-29 years-Unites States, 2000-2010. MMWR Morb Mortal Wkly Rep 61:317–322
Challacombe JM, Suhrbier A, Parsons PG, Jones B, Hampson P, Kavanagh D, Rainger GE, Morris M, Lord JM, Le TT, Hoang-Le D, Ogbourne SM (2006) Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate. J Immunol 177(11):8123–8132
Chen W, Bowden GT (1999) Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes. Oncogene 18(52):7469–7476
Chen W, Bowden GT (2000) Role of p38 mitogen-activated protein kinases in ultraviolet-B irradiation-induced activator protein 1 activation in human keratinocytes. Mol Carcinog 28(4):196–202
Chen W, Borchers AH, Dong Z, Powell MB, Bowden GT (1998) UVB irradiation-induced activator protein-1 activation correlates with increased c-fos gene expression in a human keratinocyte cell line. J Biol Chem 273(48):32176–32181
Chen N, Nomura M, She QB, Ma WY, Bode AM, Wang L, Flavell RA, Dong Z (2001a) Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res 61(10):3908–3912
Chen W, Tang Q, Gonzales MS, Bowden GT (2001b) Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes. Oncogene 20(29):3921–3926
Chen TC, Lee SA, Hong TM, Shih JY, Lai JM, Chiou HY, Yang SC, Chan CH, Kao CY, Yang PC, Huang CY (2009) From midbody protein-protein interaction network construction to novel regulators in cytokinesis. J Proteome Res 8(11):4943–4953
Chin L, Garraway LA, Fisher DE (2006) Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 20(16):2149–2182
Choi K, Lazovich D, Southwell BG, Forster J, Rolnick S, Jackson J (2010) Prevalence and characteristics of indoor tanning use among men and women in the United States. Arch Dermatol 146(12):1356–1361
Chun KS, Kundu J, Kundu JK, Surh YJ (2014) Targeting Nrf2-Keap1 signaling for chemoprevention of skin carcinogenesis with bioactive phytochemicals. Toxicol Lett 229(1):73–84
Clark LC, Combs GF et al (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. National Prevention of Cancer Study Group. JAMA 276:1957–1963
Cohen C, Zavala-Pompa A, Sequeira JH, Shoji M, Sexton DG, Cotsonis G, Cerimele F, Govindarajan B, Macaron N, Arbiser JL (2002) Mitogen-activated protein kinase activation is an early event in melanoma progression. Clin Cancer Res 8(12):3728–3733
Coso OA, Chiariello M, Kalinec G, Kyriakis JM, Woodgett J, Gutkind JS (1995) Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway. J Biol Chem 270(10):5620–5624
Craythorne E, Al-Niami F (2017) Skin cancer. Medicine 45(7):431–434
Crowell PL (1999) Prevention and therapy of cancer by dietary monoterpenes. J Nutr 129(3):775s–778s
Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL, Chanmugam A (2006) Cutaneous malignant melanoma. Mayo Clin Proc 81(4):500–507
Curran T, Franza BR Jr (1988) Fos and Jun: the AP-1 connection. Cell 55(3):395–397
CWG, I. A. R (2006) The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 120:1116–1122
Dahle J, Brunborg G, Svendsrud DH, Stokke T, Kvam E (2008) Overexpression of human OGG1 in mammalian cells decreases ultraviolet A induced mutagenesis. Cancer Lett 267(1):18–25
Davies MA, Stemke-Hale K, Tellez C, Calderone TL, Deng W, Prieto VG, Lazar AJ, Gershenwald JE, Mills GB (2008) A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer 99(8):1265–1268
De Fabo EC, Noonan FP, Fears T, Merlino G (2004) Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res 64(18):6372–6376
de Gruijl FR (2000) Photocarcinogenesis: UVA vs UVB. Methods Enzymol 319:359–366
Del Rosso JQ (2003) New and emerging topical approaches for actinic keratoses. Cutis 72(4):273–276, 279
Dellavalle RP, Nicholas MK, Schilling LM (2003) Melanoma chemoprevention: a role for statins or fibrates? Am J Ther 10(3):203–210
Demetriou SK, Ona-Vu K, Teichert AE, Cleaver JE, Bikle DD, Oh DH (2012) Vitamin D receptor mediates DNA repair and is UV inducible in intact epidermis but not in cultured keratinocytes. J Investig Dermatol 132(8):2097–2100
Denkert C, Kobel M, Berger S, Siegert A, Leclere A, Trefzer U, Hauptmann S (2001) Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61(1):303–308
Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76(6):1025–1037
Dickinson SE, Melton TF, Olson ER, Zhang J, Saboda K, Bowden GT (2009) Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: implications for chemoprevention of UVB-induced skin cancer. Cancer Res 69(17):7103–7110
Dickinson SE, Olson ER, Zhang J, Cooper SJ, Melton T, Criswell PJ, Casanova A, Dong Z, Hu C, Saboda K, Jacobs ET, Alberts DS, Bowden GT (2011) p38 MAP kinase plays a functional role in UVB-induced mouse skin carcinogenesis. Mol Carcinog 50(6):469–478
Diepgen TL, Mahler V (2002) The epidemiology of skin cancer. Br J Dermatol 146(Suppl 61):1–6
Dinehart SM (2000) The treatment of actinic keratoses. J Am Acad Dermatol 42(1 Pt 2):25–28
Dinehart SM, Nelson-Adesokan P, Cockerell C, Russell S, Brown R (1997) Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 79(5):920–923
Dinkova-Kostova AT, Jenkins SN, Fahey JW, Ye L, Wehage SL, Liby KT, Stephenson KK, Wade KL, Talalay P (2006) Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts. Cancer Lett 240(2):243–252
Dissanayake NS, Greenoak GE, Mason RS (1993) Effects of ultraviolet irradiation on human skin-derived epidermal cells in vitro. J Cell Physiol 157(1):119–127
Domann FE, Levy JP, Birrer MJ, Bowden GT (1994) Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ 5(1):9–16
Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH (1994) Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci U S A 91(2):609–613
Dong Z, Huang C, Ma WY, Malewicz B, Baumann WJ, Kiss Z (1998) Increased synthesis of phosphocholine is required for UV-induced AP-1 activation. Oncogene 17(14):1845–1853
Dorr RT, Dvorakova K et al (2000) Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4 D Phe7] alpha MSH in humans. Photochem Photobiol 72(4):526–532
Dorr RT, Ertl G, Levine N, Brooks C, Bangert JL, Powell MB, Humphrey S, Alberts DS (2004) Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers. Arch Dermatol 140(7):827–835
Downes CP, Carter AN (1991) Phosphoinositide 3-kinase: a new effector in signal transduction? Cell Signal 3(6):501–513
Dracopoli NC, Bruns GA, Brodeur GM, Landes GM, Matise TC, Seldin MF, Vance JM, Weith A (1994) Report and abstracts of the First International Workshop on Human Chromosome 1 Mapping 1994. Bethesda, Maryland, March 25-27, 1994. Cytogen Cell Genet 67(3):144–165
Drane P, Compe E, Catez P, Chymkowitch P, Egly JM (2004) Selective regulation of vitamin D receptor-responsive genes by TFIIH. Mol Cell 16(2):187–197
Dutton-Regester K, Hayward NK (2012) Reviewing the somatic genetics of melanoma: from current to future analytical approaches. Pigment Cell Melanoma Res 25(2):144–154
Dvorakova K, Dorr RT, Valcic S, Timmermann B, Alberts DS (1999) Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin. Cancer Chemother Pharmacol 43(4):331–335
Einspahr J, Alberts DS, Aickin M, Welch K, Bozzo P, Levine N, Grogan T (1996) Evaluation of proliferating cell nuclear antigen as a surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples. Cancer Epidemiol Biomark Prev 5(5):343–348
Einspahr JG, Alberts DS, Gapstur SM, Bostick RM, Emerson SS, Gerner EW (1997) Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials. Cancer Epidemiol Biomark Prev 6(1):37–48
Einspahr JG, Alberts DS, Warneke JA, Bozzo P, Basye J, Grogan TM, Nelson MA, Bowden GT (1999) Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis. Neoplasia 1(5):468–475
Einspahr JG, Nelson MA, Saboda K, Warneke J, Bowden GT, Alberts DS (2002) Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer. Clin Cancer Res 8(1):149–155
Einspahr JG, Bowden GT, Alberts DS (2003) Skin cancer chemoprevention: strategies to save our skin. Recent Results Cancer Res 163:151–164; discussion 264-156
Einspahr JG, Xu MJ, Warneke J, Saboda K, Ranger-Moore J, Bozzo P, Duckett L, Goldman R, Lin P, Buckmeier J, Alberts DS (2006) Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses. Cancer Epidemiol Biomark Prev 15(10):1841–1848
Einspahr JG, Calvert V, Alberts DS, Curiel-Lewandrowski C, Warneke J, Krouse R, Stratton SP, Liotta L, Longo C, Pellacani G, Prasad A, Sagerman P, Bermudez Y, Deng J, Bowden GT, Petricoin EF 3rd (2012) Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma. Cancer Prev Res (Phila) 5(3):403–413
Elder DE (2010) Dysplastic naevi: an update. Histopathology 56(1):112–120
Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, Bailey H, Kang S, Linden KG, Heffernan M, Duvic M, Richmond E, Elewski BE, Umar A, Bell W, Gordon GB (2010) Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst 102(24):1835–1844
English DR, Armstrong BK, Kricker A, Winter MG, Heenan PJ, Randell PL (1998) Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin: a case-control study. Int J Cancer 76(5):628–634
Erlendsson AM (2017) Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer. Dan Med J 64(11)
Facchin S, Ruzzene M, Peggion C, Sartori G, Carignani G, Marin O, Brustolon F, Lopreiato R, Pinna LA (2007) Phosphorylation and activation of the atypical kinase p53-related protein kinase (PRPK) by Akt/PKB. Cell Mol Life Sci 64(19–20):2680–2689
Farber MJ, Heilman ER, Friedman RJ (2012) Dysplastic nevi. Dermatol Clin 30(3):389–404
Fazekas Z, Gao D, Saladi RN, Lu Y, Lebwohl M, Wei H (2003) Protective effects of lycopene against ultraviolet B-induced photodamage. Nutr Cancer 47(2):181–187
Fercher AF, Mengedoht K, Werner W (1988) Eye-length measurement by interferometry with partially coherent light. Opt Lett 13(3):186–188
Fernandes NV, Guntipalli PK, Mo H (2010) d-delta-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells. Anticancer Res 30(12):4937–4944
Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, Conti CJ (1999) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 25(4):231–240
Fisher GJ, Voorhees JJ (1998) Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo. J Investig Dermatol Symp Proc 3(1):61–68
Fisher C, Byers MR, Iadarola MJ, Powers EA (1991) Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization. Development 111(2):253–258
Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371–1388
Fitzgerald LM, Fryer JL, Dwyer T, Humphrey SM (2006) Effect of MELANOTAN, [Nle(4), D-Phe(7)]-alpha-MSH, on melanin synthesis in humans with MC1R variant alleles. Peptides 27(2):388–394
Flach J, Antoni I, Villemin P, Bentzen CL, Niesor EJ (2000) The mevalonate/isoprenoid pathway inhibitor apomine (SR-45023A) is antiproliferative and induces apoptosis similar to farnesol. Biochem Biophys Res Commun 270(1):240–246
Foote JA, Harris RB, Giuliano AR, Roe DJ, Moon TE, Cartmel B, Alberts DS (2001) Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults. Int J Cancer 95(1):7–11
Frankel DH, Hanusa BH, Zitelli JA (1992) New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up. J Am Acad Dermatol 26(5 Pt 1):720–726
Fransen M, Karahalios A, Sharma N, English DR, Giles GG, Sinclair RD (2012) Non-melanoma skin cancer in Australia. Med J Aust 197(10):565–568
Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW, Bridges AJ (1994) A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265(5175):1093–1095
Funasaka Y, Boulton T, Cobb M, Yarden Y, Fan B, Lyman SD, Williams DE, Anderson DM, Zakut R, Mishima Y et al (1992) c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 3(2):197–209
Gallagher TF, Seibel GL, Kassis S, Laydon JT, Blumenthal MJ, Lee JC, Lee D, Boehm JC, Fier-Thompson SM, Abt JW, Soreson ME, Smietana JM, Hall RF, Garigipati RS, Bender PE, Erhard KF, Krog AJ, Hofmann GA, Sheldrake PL, McDonnell PC, Kumar S, Young PR, Adams JL (1997) Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase. Bioorg Med Chem 5(1):49–64
Gao G, Zhang T, Wang Q, Reddy K, Chen H, Yao K, Wang K, Roh E, Zykova T, Ma W, Ryu J, Curiel-Lewandrowski C, Alberts D, Dickinson SE, Bode AM, Xing Y, Dong Z (2017) ADA-07 suppresses solar ultraviolet-induced skin carcinogenesis by directly inhibiting TOPK. Mol Cancer Ther 16(9):1843–1854
Gause PR, Lluria-Prevatt M, Keith WN, Balmain A, Linardopolous S, Warneke J, Powell MB (1997) Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene-induced melanoma from TP-ras transgenic mice. Mol Carcinog 20(1):78–87
Gazit A, Chen J, App H, McMahon G, Hirth P, Chen I, Levitzki A (1996) Tyrphostins IV--highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolines. Bioorg Med Chem 4(8):1203–1207
Geilen CC, Wieprecht M, Orfanos CE (1996) The mitogen-activated protein kinases system (MAP kinase cascade): its role in skin signal transduction. A review. J Dermatol Sci 12(3):255–262
Geller AC, Colditz G, Oliveria S, Emmons K, Jorgensen C, Aweh GN, Frazier AL (2002) Use of sunscreen, sunburning rates, and tanning bed use among more than 10 000 US children and adolescents. Pediatrics 109(6):1009–1014
Gensler HL (1991) Prevention by alpha-difluoromethylornithine of skin carcinogenesis and immunosuppression induced by ultraviolet irradiation. J Cancer Res Clin Oncol 117(4):345–350
Gerber B, Mathys P, Moser M, Bressoud D, Braun-Fahrlander C (2002) Ultraviolet emission spectra of sunbeds. Photochem Photobiol 76(6):664–668
Ghosh S, Xie WQ, Quest AF, Mabrouk GM, Strum JC, Bell RM (1994) The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras. J Biol Chem 269(13):10000–10007
Gianpaolo-Ostravage C, Bankston D (2001) Anti-tumor efficacy of the orally active Raf kinase inhibitor BAY 43–9006 in human tumor xenograft models. Proc Am Assoc Cancer Res
Gilchrest BA, Eller MS, Geller AC, Yaar M (1999) The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340(17):1341–1348
Gillardon F, Eschenfelder C, Uhlmann E, Hartschuh W, Zimmermann M (1994) Differential regulation of c-fos, fosB, c-jun, junB, bcl-2 and bax expression in rat skin following single or chronic ultraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide superfusion. Oncogene 9(11):3219–3225
Gills JJ, Jeffery EH, Matusheski NV, Moon RC, Lantvit DD, Pezzuto JM (2006) Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion. Cancer Lett 236(1):72–79
Glazer ES, Bartels PH, Prasad AR, Yozwiak ML, Bartels HG, Einspahr JG, Alberts DS, Krouse RS (2011) Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma. Cancer Prev Res (Phila) 4(11):1770–1777
Glogau RG (2000) The risk of progression to invasive disease. J Am Acad Dermatol 42(1 Pt 2):23–24
Goldstein AM, Tucker MA (2001) Genetic epidemiology of cutaneous melanoma: a global perspective. Arch Dermatol 137(11):1493–1496
Gonzales M, Bowden GT (2002) Nordihydroguaiaretic acid-mediated inhibition of ultraviolet B-induced activator protein-1 activation in human keratinocytes. Mol Carcinog 34(2):102–111
Gordon-Thomson C, Gupta R, Tongkao-on W, Ryan A, Halliday GM, Mason RS (2012) 1alpha,25 dihydroxyvitamin D3 enhances cellular defences against UV-induced oxidative and other forms of DNA damage in skin. Photochem Photobiol Sci 11(12):1837–1847
Gould MN, Moore CJ, Zhang R, Wang B, Kennan WS, Haag JD (1994) Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras. Cancer Res 54(13):3540–3543
Goulet AC, Einsphar JG, Alberts DS, Beas A, Burk C, Bhattacharyya A, Bangert J, Harmon JM, Fujiwara H, Koki A, Nelson MA (2003) Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression. Cancer Biol Ther 2(6):713–718
Greenberg ER, Baron JA et al (1990) A clinical trial of beta carotene to prevent basal cell and squamous cell cancers of the skin. N. Eng J Med 323:789–795
Greene MH (1997) Genetics of cutaneous melanoma and nevi. Mayo Clin Proc 72(5):467–474
Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Guerry DT, Witmer WK, Thompson J, Matozzo I, Fraser MC (1985a) Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med 312(2):91–97
Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC (1985b) High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 102(4):458–465
Grimes PE, Hamzavi I, Lebwohl M, Ortonne JP, Lim HW (2013) The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. JAMA Dermatol 149(1):68–73
Grossman D, Kim PJ, Schechner JS, Altieri DC (2001) Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci U S A 98(2):635–640
Gudas LJ (1994) Retinoids and vertebrate development. J Biol Chem 269(22):15399–15402
Gupta A, Myrdal PB (2004) Development of a perillyl alcohol topical cream formulation. Int J Pharm 269(2):373–383
Gupta AK, Cherman AM, Tyring SK (2004) Viral and nonviral uses of imiquimod: a review. J Cutan Med Surg 8(5):338–352
Guy GP Jr, Machlin SR, Ekwueme DU, Yabroff KR (2015) Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med 48(2):183–187
Haag JD, Gould MN (1994) Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother Pharmacol 34(6):477–483
Haake AR, Polakowska RR (1993) Cell death by apoptosis in epidermal biology. J Invest Dermatol 101(2):107–112
Hacker E, Irwin N, Muller HK, Powell MB, Kay G, Hayward N, Walker G (2005) Neonatal ultraviolet radiation exposure is critical for malignant melanoma induction in pigmented Tpras transgenic mice. J Invest Dermatol 125(5):1074–1077
Hacker E, Muller HK, Irwin N, Gabrielli B, Lincoln D, Pavey S, Powell MB, Malumbres M, Barbacid M, Hayward N, Walker G (2006) Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice. Cancer Res 66(6):2946–2952
Hadley ME, Dorr RT (2006) Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides 27(4):921–930
Halaban R, Fan B, Ahn J, Funasaka Y, Gitay-Goren H, Neufeld G (1992) Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes. J Immunother 12(3):154–161
Halachmi S, Gilchrest BA (2001) Update on genetic events in the pathogenesis of melanoma. Curr Opin Oncol 13(2):129–136
Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R et al (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162(4):285–294
Haluska FG, Hodi FS (1998) Molecular genetics of familial cutaneous melanoma. J Clin Oncol 16(2):670–682
Hampson P, Kavanagh D, Smith E, Wang K, Lord JM, Ed Rainger G (2008) The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-delta dependent manner. Cancer Immunol Immunother 57(8):1241–1251
Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS (2001) c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108(1):73–81
Handler MZ, Bloom BS, Goldberg DJ (2017) Clinical and histologic evaluation of ingenol mebutate 0.015% gel for the cosmetic improvement of photoaged skin. Dermatol Surg 44(1):61–67
Hanke CW, Berman B, Swanson N, Pariser DM, Weiss JS, Bukhalo M, Skov T, Villumsen J, Siegel D (2017) Safety and efficacy of escalating doses of ingenol mebutate for field treatment of actinic keratosis on the full face, full balding scalp, or chest. J Drugs Dermatol 16(5):438–444
Harris RB, Griffith K, Moon TE (2001a) Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 45(4):528–536
Harris RE, Beebe-Donk J, Namboodiri KK (2001b) Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women. Oncol Rep 8(3):655–657
He F, Yan Q, Fan L, Liu Y, Cui J, Wang J, Wang L, Wang Y, Wang Z, Guo Y, Huang G (2010) PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma. Hum Pathol 41(3):415–424
Healy E, Flannagan N, Ray A, Todd C, Jackson IJ, Matthews JN, Birch-Machin MA, Rees JL (2000) Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 355(9209):1072–1073
Herbert JL, Khugyani F et al (2001) Chemoprevention of basal cell carcinoma in the ptc1 +/- mouse-green and black tea. Skin Pharmacol Appl Skin Physiol 14(6):358–362
Herlyn M, Satyamoorthy K (1996) Activated ras. Yet another player in melanoma? Am J Pathol 149(3):739–744
Hery C, Tryggvadottir L, Sigurdsson T, Olafsdottir E, Sigurgeirsson B, Jonasson JG, Olafsson JH, Boniol M, Byrnes GB, Dore JF, Autier P (2010) A melanoma epidemic in Iceland: possible influence of sunbed use. Am J Epidemiol 172(7):762–767
Hill CS, Treisman R (1995) Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80(2):199–211
Hohl RJ, Lewis K (1995) Differential effects of monoterpenes and lovastatin on RAS processing. J Biol Chem 270(29):17508–17512
Hu F, Gartenhaus RB, Eichberg D, Liu Z, Fang HB, Rapoport AP (2010) PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Oncogene 29(40):5464–5474
Huang C, Ma W, Ding M, Bowden GT, Dong Z (1997a) Direct evidence for an important role of sphingomyelinase in ultraviolet-induced activation of c-Jun N-terminal kinase. J Biol Chem 272(44):27753–27757
Huang C, Ma WY, Hecht SS, Dong Z (1997b) Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3′ kinase. Cancer Res 57(14):2873–2878
Huang C, Ma WY, Ryan CA, Dong Z (1997c) Proteinase inhibitors I and II from potatoes specifically block UV-induced activator protein-1 activation through a pathway that is independent of extracellular signal-regulated kinases, c-Jun N-terminal kinases, and P38 kinase. Proc Natl Acad Sci U S A 94(22):11957–11962
Huang C, Li J, Chen N, Ma W, Bowden GT, Dong Z (2000) Inhibition of atypical PKC blocks ultraviolet-induced AP-1 activation by specifically inhibiting ERKs activation. Mol Carcinog 27(2):65–75
Hunter T (1997) Oncoprotein networks. Cell 88(3):333–346
Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nat Genet 8(1):15–21
Hwang MK, Bode AM, Byun S, Song NR, Lee HJ, Lee KW, Dong Z (2010) Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1. Cancer Res 70(17):6859–6869
Ibuki Y, Allanson M, Dixon KM, Reeve VE (2007) Radiation sources providing increased UVA/UVB ratios attenuate the apoptotic effects of the UVB waveband UVA-dose-dependently in hairless mouse skin. J Invest Dermatol 127(9):2236–2244
International Medical News Group (2002). Nonmelanoma skin cancer new solutions to treatments. Suppl Skin Allergy News
Iotzova-Weiss G, Freiberger SN, Johansen P, Kamarachev J, Guenova E, Dziunycz PJ, Roux GA, Neu J, Hofbauer GFL (2017) TLR4 as a negative regulator of keratinocyte proliferation. PLoS One 12(10):e0185668
Irinopoulou T, Rigaut JP, Benson MC (1993) Toward objective prognostic grading of prostatic carcinoma using image analysis. Anal Quant Cytol Histol 15(5):341–344
Ishibashi M, Arai M, Tanaka S, Onda K, Hirano T (2012) Antiproliferative and apoptosis-inducing effects of lipophilic vitamins on human melanoma A375 cells in vitro. Biol Pharm Bull 35(1):10–17
Ja B, Li G (2003) The role of Bcl-2 family members in the progression of cutaneous melanoma. Clin Exp Metastasis 20(6):531–539
Jain N, Rademaker A, Robinson JK (2012) Implementation of the federal excise tax on indoor tanning services in Illinois. Arch Dermatol 148(1):122–124
Janda J, Burkett NB, Blohm-Mangone K, Huang V, Curiel-Lewandrowski C, Alberts DS, Petricoin EF 3rd, Calvert VS, Einspahr J, Dong Z, Bode AM, Wondrak GT, Dickinson SE (2016) Resatorvid-based pharmacological antagonism of cutaneous TLR4 blocks UV-induced NF-kappaB and AP-1 signaling in keratinocytes and mouse skin. Photochem Photobiol 92(6):816–825
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275(5297):218–220
Jansen B, Wacheck V, Heere-Ress E, Schlagbauer-Wadl H, Hoeller C, Lucas T, Hoermann M, Hollenstein U, Wolff K, Pehamberger H (2000) Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet 356(9243):1728–1733
Jemal A, Saraiya M, Patel P, Cherala SS, Barnholtz-Sloan J, Kim J, Wiggins CL, Wingo PA (2011) Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol 65(5 Suppl 1):S17–25.e11-13
John PR, Ramsay M (2002) Four novel variants in MC1R in red-haired South African individuals of European descent: S83P, Y152X, A171D, P256S. Hum Mutat 19(4):461–462
Juge N, Mithen RF, Traka M (2007) Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64(9):1105–1127
Kabuyama Y, Hamaya M, Homma Y (1998) Wavelength specific activation of PI 3-kinase by UVB irradiation. FEBS Lett 441(2):297–301
Kallunki T, Su B, Tsigelny I, Sluss HK, Derijard B, Moore G, Davis R, Karin M (1994) JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 8(24):2996–3007
Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J et al (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8(1):23–26
Kapadia GJ, Azuine MA, Tokuda H, Takasaki M, Mukainaka T, Konoshima T, Nishino H (2002) Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol Res 45(6):499–505
Kedei N, Lundberg DJ, Toth A, Welburn P, Garfield SH, Blumberg PM (2004) Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res 64(9):3243–3255
Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN (2001) Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117(2):294–300
Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26(4):239–257
Khan AQ, Travers JB, Kemp MG (2018) Roles of UVA radiation and DNA damage responses in melanoma pathogenesis. Environ Mol Mutagen 21:21
Kim DJ, Li Y, Reddy K, Lee MH, Kim MO, Cho YY, Lee SY, Kim JE, Bode AM, Dong Z (2012) Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth. Cancer Res 72(12):3060–3068
Koh HK, Geller AC, Miller DR, Grossbart TA, Lew RA (1996) Prevention and early detection strategies for melanoma and skin cancer. Current status. Arch Dermatol 132(4):436–443
Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR (1993) Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364(6434):249–252
Konig H, Ponta H, Rahmsdorf HJ, Herrlich P (1992) Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 11(6):2241–2246
Kopp P (1998) Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the ‘French paradox’? Eur J Endocrinol 138(6):619–620
Kuehl PJ, Angersbach BS, Stratton SP, Myrdal PB (2006) Development of an HPLC method for the analysis of Apomine in a topical cream formulation. J Pharm Biomed Anal 40(4):975–980
Kuo WT, Lee TC, Yu LC (2016) Eritoran suppresses colon cancer by altering a functional balance in toll-like receptors that bind lipopolysaccharide. Cancer Res 76(16):4684–4695
Lahti JM, Xiang J, Kidd VJ (1995) The PITSLRE protein kinase family. Prog Cell Cycle Res 1:329–338
Lambert JD, Meyers RO, Timmermann BN, Dorr RT (2001) tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo. Cancer Lett 171(1):47–56
Larsen HK, Banzhaf CA, Thomsen SF, Gormsen M, Schopf RE, Haedersdal M (2017) An exploratory, prospective, open-label trial of ingenol mebutate gel 0.05% for the treatment of external anogenital warts. J Eur Acad Dermatol Venereol
Lazovich D, Vogel RI, Berwick M, Weinstock MA, Anderson KE, Warshaw EM (2010) Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomark Prev 19(6):1557–1568
Lazovich D, Choi K, Vogel RI (2012) Time to get serious about skin cancer prevention. Cancer Epidemiol Biomark Prev 21(11):1893–1901
Le Clair MZ, Cockburn MG (2016) Tanning bed use and melanoma: establishing risk and improving prevention interventions. Preven Med Reports 3:139–144
Lear W, Dahlke E, Murray CA (2007) Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors. J Cutan Med Surg 11(1):19–30
Lee W, Haslinger A, Karin M, Tjian R (1987) Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 325(6102):368–372
Lee JC, Griswold DE, Votta B, Hanna N (1988) Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002. Int J Immunopharmacol 10(7):835–843
Lee JC, Badger AM, Griswold DE, Dunnington D, Truneh A, Votta B, White JR, Young PR, Bender PE (1993) Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann N Y Acad Sci 696:149–170
Lee SK, Song L, Mata-Greenwood E, Kelloff GJ, Steele VE, Pezzuto JM (1999) Modulation of in vitro biomarkers of the carcinogenic process by chemopreventive agents. Anticancer Res 19(1a):35–44
Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL (2000) Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 47(2–3):185–201
Levine N, Dorr RT, Ertl GA, Brooks C, Alberts DS (1999) Effects of a potent synthetic melanotropin NI4-D-Phe2 MSH(Melanotan 1) on tanning: a dose range study. J Dermatolog Treat 10:127–132
Li G, Herlyn M (2000) Dynamics of intercellular communication during melanoma development. Mol Med Today 6(4):163–169
Li G, Mitchell DL, Ho VC, Reed JC, Tron VA (1996) Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice. Am J Pathol 148(4):1113–1123
Li G, Satyamoorthy K, Herlyn M (2002) Dynamics of cell interactions and communications during melanoma development. Crit Rev Oral Biol Med 13(1):62–70
Li X, Wu X, Chen Q (2014) Statin use is not associated with reduced risk of skin cancer: a meta-analysis. Br J Cancer 110:802–807
Liaw GJ, Steingrimsson E, Pignoni F, Courey AJ, Lengyel JA (1993) Characterization of downstream elements in a Raf-1 pathway. Proc Natl Acad Sci U S A 90(3):858–862
Liggett WH Jr, Sidransky D (1998) Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16(3):1197–1206
Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA (2009) Increasing burden of melanoma in the United States. J Investig Dermatol 129(7):1666–1674
Lippman SM, Brown PH (1999) Tamoxifen prevention of breast cancer: an instance of the fingerpost. J Natl Cancer Inst 91(21):1809–1819
Lippman SM, Hong WK (2002) Cancer prevention by delay. Commentary re: J. A. O’Shaughnessy et al., Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin. Cancer Res., 8: 314-346, 2002. Clin Cancer Res 8(2):305–313
Lluria-Prevatt M, Morreale J, Gregus J, Alberts DS, Kaper F, Giaccia A, Powell MB (2002) Effects of perillyl alcohol on melanoma in the TPras mouse model. Cancer Epidemiol Biomark Prev 11(6):573–579
Lober BA, Fenske NA (2004) Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma). Am J Clin Dermatol 5(6):395–401
Lorusso PM (2003) Phase I studies of ZD1839 in patients with common solid tumors. Semin Oncol 30(1 Suppl 1):21–29
Lu YP, Lou YR, Lin Y, Shih WJ, Huang MT, Yang CS, Conney AH (2001) Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Cancer Res 61(13):5002–5009
Lucas RM, McMichael AJ, Armstrong BK, Smith WT (2008) Estimating the global disease burden due to ultraviolet radiation exposure. Int J Epidemiol 37(3):654–667
Luo C, Sheng J, Hu M (2013) Loss of ARF sensitizes transgenic BRAF V600E mice to UV-induced melanoma via suppression of XPC. Cancer Res 73:4337–4348
Luo H, Umebayashi M, Doi K, Morisaki T, Shirasawa S, Tsunoda T (2016) Resveratrol overcomes cellular resistance to Vemurafenib through dephosphorylation of AKT in BRAF-mutated melanoma cells. Anticancerr Res 36:3585–3589
Lyons JF, Wilhelm S, Hibner B, Bollag G (2001) Discovery of a novel Raf kinase inhibitor. Endocr Relat Cancer 8(3):219–225
MacAulay C, Lam S, Payne PW, LeRiche JC, Palcic B (1995) Malignancy-associated changes in bronchial epithelial cells in biopsy specimens. Anal Quant Cytol Histol 17(1):55–61
Madan V, Bisset D, Harris P, Howard S, Beck MH (2006) Phaeohyphomycosis caused by Exophiala salmonis. Br J Dermatol 155(5):1082–1084
Maden V, Leah JT, Szeimies RM (2010) Non-melanoma skin cancer. Lancet 375:673–685
Mandel ID (1988) Chemotherapeutic agents for controlling plaque and gingivitis. J Clin Periodontol 15(8):488–498
Mangelsdorf D, Unesonso K et al (1994) The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS (eds) The retinoids. Raven Press, New York, pp 319–349
Manson JE, Rexrode KM, Garland FC, Garland CF, Weinstock MA (2000) The case for a comprehensive national campaign to prevent melanoma and associated mortality. Epidemiology 11(6):728–734
Marks R (1999) Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now? Australas J Dermatol 40(1):1–5
Marras S, Faa G, Dettori T, Congiu L, Vanni R (1999) Chromosomal changes in dysplastic nevi. Cancer Genet Cytogenet 113(2):177–179
Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80(2):179–185
Martin G, Swanson N (2013) Clinical findings using ingenol mebutate gel to treat actinic keratoses. J Am Acad Dermatol 68(1 Suppl 1):S39–S48
Matsumoto S, Abe Y, Fujibuchi T, Takeuchi T, Kito K, Ueda N, Shigemoto K, Gyo K (2004) Characterization of a MAPKK-like protein kinase TOPK. Biochem Biophys Res Commun 325(3):997–1004
Matsumura Y, Nishigori C, Yagi T, Imamura S, Takebe H (1996) Characterization of p53 gene mutations in basal-cell carcinomas: comparison between sun-exposed and less-exposed skin areas. Int J Cancer 65(6):778–780
McEwan LE, Smith JG (1997) Topical diclofenac/hyaluronic acid gel in the treatment of solar keratoses. Australas J Dermatol 38(4):187–189
Melamed RD, Aydin IT, Rajan GS, Phelps R, Silvers DN, Emmett KJ, Brunner G, Rabadan R, Celebi JT (2017) Genomic characterization of dysplastic nevi unveils implications for diagnosis of melanoma. J Investig Dermatol 137(4):905–909
Meyskens FL Jr (1988) Thinking about cancer causality and chemoprevention. J Natl Cancer Inst 80(16):1278–1281
Meyskens FL Jr, Farmer PJ, Anton-Culver H (2004) Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk. Clin Cancer Res 10(8):2581–2583
Meyskens FL, Kingsley EM, Glattke T, Loescher L, Booth A (1986) A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma. Investig New Drugs 4(3):257–262
Mills JJ, Chari RS, Boyer IJ, Gould MN, Jirtle RL (1995) Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res 55(5):979–983
Mitscher LA, Park YH, Clark D, Clark GW 3rd, Hammesfahr PD, Wu WN, Beal JL (1978) Antimicrobial agents from higher plants. An investigation of Hunnemannia fumariaefolia pseudoalcoholates of sanguinarine and chelerythrine. Lloydia 41(2):145–150
Montagnani Marelli M, Marzagalli M, Moretti RM, Beretta G, Casati L, Comitato R, Gravina GL, Festuccia C, Limonta P (2016) Vitamin E delta-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells. Sci Rep 6:30502
Montes de Oca MK, Pearlman RL, McClees SF, Strickland R, Afaq F (2017) Phytochemicals for the Prevention of Photocarcinogenesis. Photochem Photobiol 93(4):956–974
Moon TE, Levine N et al (1997) Effect of retinol in preventing squamous cell skin cancer in moderate risk subjects: a randomized, double blind, controlled trial, Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev 6(11):949–956
Morse MA, Stoner GD (1993) Cancer chemoprevention: principles and prospects. Carcinogenesis 14(9):1737–1746
Nakazawa H, English D, Randell PL, Nakazawa K, Martel N, Armstrong BK, Yamasaki H (1994) UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci U S A 91(1):360–364
Narayanan DL, Saladi RN, Fox JL (2010) Ultraviolet radiation and skin cancer. Int J Dermatol 49(9):978–986
Nelson MA, Einspahr JG, Alberts DS, Balfour CA, Wymer JA, Welch KL, Salasche SJ, Bangert JL, Grogan TM, Bozzo PO (1994) Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 85(1):23–29
Nelson MA, Ariza ME, Yang JM, Thompson FH, Taetle R, Trent JM, Wymer J, Massey-Brown K, Broome-Powell M, Easton J, Lahti JM, Kidd VJ (1999) Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma. Cancer Gen Cytogen 108(2):91–99
Niesor EJ, Flach J (1999) Synthetic Farnesoid X Receptor (FXR) agonists: a new class of cholesterol synthesis inhibitors and antiproliferative drugs. Drugs Future 24:431–438
Nomura M, Ma WY, Huang C, Yang CS, Bowden GT, Miyamoto K, Dong Z (2000) Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea. Mol Carcinog 28(3):148–155
Nomura M, Kaji A, He Z, Ma WY, Miyamoto K, Yang CS, Dong Z (2001a) Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 276(49):46624–46631
Nomura M, Kaji A, Ma WY, Zhong S, Liu G, Bowden GT, Miyamoto KI, Dong Z (2001b) Mitogen- and stress-activated protein kinase 1 mediates activation of Akt by ultraviolet B irradiation. J Biol Chem 276(27):25558–25567
Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, De Fabo EC, Merlino G (2001) Neonatal sunburn and melanoma in mice. Nature 413(6853):271–272
Ogbourne SM, Suhrbier A, Jones B, Cozzi SJ, Boyle GM, Morris M, McAlpine D, Johns J, Scott TM, Sutherland KP, Gardner JM, Le TT, Lenarczyk A, Aylward JH, Parsons PG (2004) Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res 64(8):2833–2839
Oh SM, Zhu F, Cho YY, Lee KW, Kang BS, Kim HG, Zykova T, Bode AM, Dong Z (2007) T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation. Cancer Res 67(11):5186–5194
Omholt K, Krockel D, Ringborg U, Hansson J (2006) Mutations of PIK3CA are rare in cutaneous melanoma. Melanoma Res 16(2):197–200
Orengo IF, Gerguis J, Phillips R, Guevara A, Lewis AT, Black HS (2002) Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model. Arch Dermatol 138(6):751–755
Ortega Del Olmo R, Salido-Vallejo R (2017) Ingenol mebutate for the treatment of actinic keratosis: effectiveness and safety in 246 patients treated in real-life clinical practice. J Dermatolog Treat 29(4):393–399
Ortonne JP (2002) Photobiology and genetics of malignant melanoma. Br J Dermatol 146(Suppl 61):11–16
O’Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ, Sigman CC, Bertagnolli MM, Stratton SP, Lam S, Nelson WG, Meyskens FL, Alberts DS, Follen M, Rustgi AK, Papadimitrakopoulou V, Scardino PT, Gazdar AF, Wattenberg LW, Sporn MB, Sakr WA, Lippman SM, Von Hoff DD (2002) Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 8(2):314–346
Oyagbemi AA, Saba AB, Azeez OI (2010) Capsaicin: novel chemopreventive molecule and its underlying molecular mechanisms of action. Indian J Cancer 47(1):53–58
Pacifico A, Goldberg LH, Peris K, Chimenti S, Leone G, Ananthaswamy HN (2008) Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers.[Erratum appears in Br J Dermatol. 2008 Mar;158(3):657]. Br J Dermatol 158(2):291–297
Pagoto SL, Baker K, Griffith J, Oleski JL, Palumbo A, Walkosz BJ, Hillhouse J, Henry KL, Buller DB (2016) Engaging moms on teen indoor tanning through social media: protocol of a randomized controlled trial. JMIR Res Prot 5(4):e228
Pal HC, Baxter RD, Hunt KM, Agarwal J, Elmets CA, Athar M, Afaq F (2015) Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells. Oncotarget 6(29):28296–28311
Pal HC, Diamond AC, Strickland LR, Kappes JC, Katiyar SK, Elmets CA, Athar M, Afaq F (2016) Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma. Oncotarget 7(2):1227–1241
Palmer JS, Duffy DL, Box NF, Aitken JF, O’Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66(1):176–186
Park JH, Nishidate T, Nakamura Y, Katagiri T (2010) Critical roles of T-LAK cell-originated protein kinase in cytokinesis. Cancer Sci 101(2):403–411
Pena JC, Rudin CM, Thompson CB (1998) A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res 58(10):2111–2116
Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R (1999) Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 20(10):1939–1944
Peyssonnaux C, Eychene A (2001) The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell 93(1–2):53–62
Piepkorn M (2000) The expression of p16(INK4a), the product of a tumor suppressor gene for melanoma, is upregulated in human melanocytes by UVB irradiation. J Am Acad Dermatol 42(5 Pt 1):741–745
Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN (1991) Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 4(3):196–202
Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS (2003) High frequency of BRAF mutations in nevi. Nat Genet 33(1):19–20
Ponti G, Manfredini M, Greco S, Pellacani G, Depenni R, Tomasi A, Maccaferri M, Cascinu S (2017) BRAF, NRAS and C-KIT Advanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival. Anticancer Res 37(12):7043–7048
Porter RS (2011) The Merck manual of diagnosis and therapy. Merck Sharp & Dohme Corp, West Point, PA
Pourpak A, Dorr R (2005) Anti-melanoma activity of the bisphosphonate ester APOMINE is independent of Ras Farnesylation and apoptotic cell death in human melanoma cell lines. Am Assoc Cancer Res
Powell M, Alberts D (2002) Preclinical and clinical activity of Apomine, a novel bisphosphonate ester in the prevention and treatment of melanoma. Proc Am Assoc Cancer Res
Powis G, Berggren M, Gallegos A, Frew T, Hill S, Kozikowski A, Bonjouklian R, Zalkow L, Abraham R, Ashendel C et al (1995) Advances with phospholipid signalling as a target for anticancer drug development. Acta Biochim Pol 42(4):395–403
Quinn AG, Sikkink S, Rees JL (1994) Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res 54(17):4756–4759
Rallis E, Liakopoulou A, Christodoulopoulos C (2017) Ingenol mebutate for the treatment of intraepidermal squamous cell carcinoma. J Clin Aesthet Dermatol 10(7):12–13
Ramirez CC, Ma F, Federman DG, Kirsner RS (2005) Use of cyclooxygenase inhibitors and risk of melanoma in high-risk patients. Dermatol Surg 31(7 Pt 1):748–752
Ranger-Moore J, Alberts DS, Montironi R, Garcia F, Davis J, Frank D, Brewer M, Mariuzzi GM, Bartels HG, Bartels PH (2005) Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer 41(13):1875–1888
Reagan-Shaw S, Afaq F, Aziz MH, Ahmad N (2004) Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 23(30):5151–5160
Reagan-Shaw S, Breur J, Ahmad N (2006) Enhancement of UVB radiation-mediated apoptosis by sanguinarine in HaCaT human immortalized keratinocytes. Mol Cancer Ther 5(2):418–429
Reed JA, Loganzo F Jr, Shea CR, Walker GJ, Flores JF, Glendening JM, Bogdany JK, Shiel MJ, Haluska FG, Fountain JW et al (1995) Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 55(13):2713–2718
Rehman I, Takata M, Wu YY, Rees JL (1996) Genetic change in actinic keratoses. Oncogene 12(12):2483–2490
Report SG (2014) The Surgeon General’s call to action to prevent skin cancer. Services USDoHaH. Reports for the Surgeon General. Office of the Surgeon General, Washington DC
Richmond A, Fine R, Murray D, Lawson DH, Priest JH (1986) Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J Invest Dermatol 86(3):295–302
Rigel DS (2010) Epidemiology of melanoma. Sem Cutan Med Surg 29(4):204–209
Rivers JK, McLean DI (1997) An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. Arch Dermatol 133(10):1239–1242
Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y (2002) Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol 146(1):94–100
Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J (1999) Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 341(6):410–418
Runger TM (1999) Role of UVA in the pathogenesis of melanoma and non-melanoma skin cancer. A short review. Photodermatol Photoimmunol Photomed 15(6):212–216
Runger TM (2007) How different wavelengths of the ultraviolet spectrum contribute to skin carcinogenesis: the role of cellular damage responses. J Invest Dermatol 127(9):2103–2105
Runger TM, Kappes UP (2008) Mechanisms of mutation formation with long-wave ultraviolet light (UVA). Photodermatol Photoimmunol Photomed 24(1):2–10
Russo I, Caroppo F, Alaibac M (2015) Vitamins and melanoma. Cancers 7(3):1371–1387
Ryseck RP, Hirai SI, Yaniv M, Bravo R (1988) Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature 334(6182):535–537
Salasche SJ (2000) Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 42(1 Pt 2):4–7
Sample A, He YY (2017) Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed 34(1):13–24
Samuels ML, Weber MJ, Bishop JM, McMahon M (1993) Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol 13(10):6241–6252
Setlow RB, Grist E, Thompson K, Woodhead AD (1993) Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A 90(14):6666–6670
Shah M, Stebbins JL, Dewing A, Qi J, Pellecchia M, Ronai ZA (2009) Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis. Pigment Cell Melanoma Res 22(6):799–808
Shamma M, Guinaudeau H (1986) Aporphinoid alkaloids. Nat Prod Rep 3(4):345–351
Sherman A, Koss L (1983) Morphometry of benign urothelial cells in the presence of cancer. Anal Quant Cytol Histol 5:221
Sherwani MA, Tufail S, Muzaffar AF, Yusuf N (2018) The skin microbiome and immune system: Potential target for chemoprevention? Photodermatol Photoimmunol Photomed 34(1):25–34
Shibata A, Nakagawa K, Yamanoi H, Tsuduki T, Sookwong P, Higuchi O, Kimura F, Miyazawa T (2010) Sulforaphane suppresses ultraviolet B-induced inflammation in HaCaT keratinocytes and HR-1 hairless mice. J Nutr Biochem 21(8):702–709
Silvers AL, Bowden GT (2002) UVA irradiation-induced activation of activator protein-1 is correlated with induced expression of AP-1 family members in the human keratinocyte cell line HaCaT. Photochem Photobiol 75(3):302–310
Silvers AL, Bachelor MA, Bowden GT (2003) The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression. Neoplasia 5(4):319–329
Simons-Evelyn M, Bailey-Dell K, Toretsky JA, Ross DD, Fenton R, Kalvakolanu D, Rapoport AP (2001) PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt’s lymphoma and other highly proliferative malignant cells. Blood Cells Mol Dis 27(5):825–829
Skin Cancer Foundation (2015) Skin cancer facts & statistics
Sober AJ, Burstein JM (1995) Precursors to skin cancer. Cancer 75(2 Suppl):645–650
Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, Benard J, Paillerets B B-d (1999a) Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.[Erratum appears in Hum Mol Genet 1998 May;7(5):941]. Hum Mol Genet 7(2):209–216
Soufir N, Moles JP, Vilmer C, Moch C, Verola O, Rivet J, Tesniere A, Dubertret L, Basset-Seguin N (1999b) P16 UV mutations in human skin epithelial tumors. Oncogene 18(39):5477–5481
Soufir N, Daya-Grosjean L, de La Salmoniere P, Moles JP, Dubertret L, Sarasin A, Basset-Seguin N (2000) Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. J Natl Cancer Inst 92(22):1841–1847
Spencer JM, Kahn SM, Jiang W, DeLeo VA, Weinstein IB (1995) Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 131(7):796–800
Spencer JM, Hazan C, Hsiung SH, Robins P (2005) Therapeutic decision making in the therapy of actinic keratoses. J Drugs Dermatol 4(3):296–301
Sporn MB, Suh N (2000) Chemoprevention of cancer. Carcinogenesis 21(3):525–530
Stahlhut M, Bertelsen M, Hoyer-Hansen M, Svendsen N, Eriksson AH, Lord JM, Scheel-Toellner D, Young SP, Zibert JR (2012) Ingenol mebutate: induced cell death patterns in normal and cancer epithelial cells. J Drugs Dermatol 11(10):1181–1192
Stam-Posthuma JJ, Vink J, le Cessie S, Bruijn JA, Bergman W, Pavel S (1998) Effect of topical tretinoin under occlusion on atypical naevi. Melanoma Res 8(6):539–548
Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W (2001) Multiple primary melanomas. J Am Acad Dermatol 44(1):22–27
Stayrook KR, McKinzie JH, Barbhaiya LH, Crowell PL (1998) Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells. Anticancer Res 18(2a):823–828
Stein B, Angel P, van Dam H, Ponta H, Herrlich P, van der Eb A, Rahmsdorf HJ (1992) Ultraviolet-radiation induced c-jun gene transcription: two AP-1 like binding sites mediate the response. Photochem Photobiol 55(3):409–415
Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas MA, Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342(26):1946–1952
Stolz W, Vogt T, Landthaler M, Hempfer S, Bingler P, Abmayr W (1994) Differentiation between malignant melanomas and benign melanocytic nevi by computerized DNA cytometry of imprint specimens. J Cutan Pathol 21(1):7–15
Stratton SP (2001) Prevention of non-melanoma skin cancer. Curr Oncol Rep 3(4):295–300
Stratton SP, Dorr RT, Alberts DS (2000) The state-of-the-art in chemoprevention of skin cancer. Eur J Cancer 36(10):1292–1297
Stratton SP, Alberts DS, Einspahr JG, Sagerman PM, Warneke JA, Curiel-Lewandrowski C, Myrdal PB, Karlage KL, Nickoloff BJ, Brooks C, Saboda K, Yozwiak ML, Krutzsch MF, Hu C, Lluria-Prevatt M, Dong Z, Bowden GT, Bartels PH (2010) A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer. Cancer Prev Res (Phila) 3(2):160–169
Straume O, Akslen LA (1997) Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. Int J Cancer 74(5):535–539
Strumberg D, Schuehly W, Moeller J, Hedler D, Hilger R, Stellberg W, Richly H, Heinig R, Ahr G, Wensing G, Kuhlmann J, Scheulen M, Seeber S (2001) Phase I clinical, pharmacokinetic and pharmacodynamic study of the Raf kinase inhibitor BAY 49–9006 in patients with locally advanced or metastatic cancer. Proc Am Assoc Cancer Res 330
Sun AY, Simonyi A, Sun GY (2002) The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med 32(4):314–318
Susnik B, Worth A, LeRiche J, Palcic B (1995) Malignancy-associated changes in the breast. Changes in chromatin distribution in epithelial cells in normal-appearing tissue adjacent to carcinoma. Anal Quant Cytol Histol 17(1):62–68
Swerdlow AJ, Weinstock MA (1998) Do tanning lamps cause melanoma? An epidemiologic assessment. J Am Acad Dermatol 38(1):89–98
Tada A, Pereira E, Beitner-Johnson D, Kavanagh R, Abdel-Malek ZA (2002) Mitogen- and ultraviolet-B-induced signaling pathways in normal human melanocytes. J Invest Dermatol 118(2):316–322
Takigawa M, Enormoto M (1990) Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in vivo and the proliferation of vascular endothelial cells in vitro. Cancer Res 50(13):4131–4138
Talalay P, Fahey JW, Healy ZR, Wehage SL, Benedict AL, Min C, Dinkova-Kostova AT (2007) Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc Natl Acad Sci U S A 104(44):17500–17505
Tang Q, Gonzales M, Inoue H, Bowden GT (2001) Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes. Cancer Res 61(11):4329–4332
Tangrea JA, Edwards BK et al (1992) Long term therapy with low dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. J Natl Cancer Inst 84:328–332
The International Agency for Research on Cancer Working Group on Artificial Ultraviolet (UV) Light and Skin Cancer (2007) The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer 120(5):1116–1122
Thomas T, Bozzo P (2006) Biomarkers of angiogenesis in progression from dysplastic nevi to malignant melanoma. Society of Investigative Dermatology, Philadelphia
Thompson FH, Emerson J, Olson S, Weinstein R, Leavitt SA, Leong SP, Emerson S, Trent JM, Nelson MA, Salmon SE et al (1995) Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes. Cancer Genet Cytogenet 83(2):93–104
Tsao H (2001) Genetics of nonmelanoma skin cancer. Arch Dermatol 137(11):1486–1492
Tsao H, Mihm M, Sheehan C (2003) PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma. J Am Acad Dermatol 49(5):865–872
Uhlman M (2002) Teens take risks for tans: sunscreen often goes by the wayside, a study shows. FDA is evaluating labeling. Philadelphia Inquirer, Philadelphia, PA, p A08
Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A, Jackson IJ, Rees JL (1996) The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 5(10):1663–1666
Vavreckova C, Ulrichova J, Hajduch M, Grambal F, Weigl E, Simanek V (1994) Effect of quaternary benzo[c]phenanthridine alkaloids sanguinarine, chelerythrine and fagaronine on some mammalian cells. Acta Univ Palacki Olomuc Fac Med 138:7–10
Veierod MB, Weiderpass E, Thorn M, Hansson J, Lund E, Armstrong B, Adami HO (2003) A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 95(20):1530–1538
Viros A, Sanchez-Laorden B, Pedersen M, Furney SJ, Rae J, Hogan K, Ejiama S, Girotti MR, Cook M, Dhomen N, Marais R (2014) Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature 511(7510):478–482
Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2(7):489–501
Volkov A, Dobbinson S, Wakefield M, Slevin T (2013) Seven-year trends in sun protection and sunburn among Australian adolescents and adults. Aust N Z J Public Health 37(1):63–69
Wakeling AE (2002) Epidermal growth factor receptor tyrosine kinase inhibitors. Curr Opin Pharmacol 2(4):382–387
Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1(6):570–577
Wan YS, Wang ZQ, Shao Y, Voorhees JJ, Fisher GJ (2001a) Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo. Int J Oncol 18(3):461–466
Wan YS, Wang ZQ, Voorhees J, Fisher G (2001b) EGF receptor crosstalks with cytokine receptors leading to the activation of c-Jun kinase in response to UV irradiation in human keratinocytes. Cell Signal 13(2):139–144
Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, Bart RS (2001) Ultraviolet A and melanoma: a review. J Am Acad Dermatol 44(5):837–846
Warne PH, Viciana PR, Downward J (1993) Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364(6435):352–355
Watson M, Shoemaker M, Baker K (2017) Indoor tanning initiation among tanners in the United States. JAMA Dermatol 53(5):470–472
Weinzweig J, Tattini C, Lynch S, Zienowicz R, Weinzweig N, Spangenberger A, Edstrom L (2003) Investigation of the growth and metastasis of malignant melanoma in a murine model: the role of supplemental vitamin A. Plast Reconstr Surg 112(1):152–158; discussion 159-161
Wellbrock C, Ogilvie L, Hedley D, Karasarides M, Martin J, Niculescu-Duvaz D, Springer CJ, Marais R (2004) V599EB-RAF is an oncogene in melanocytes. Cancer Res 64(7):2338–2342
Welzel J (2001) Optical coherence tomography in dermatology: a review. Skin Res Technol 7(1):1–9
Weng H, Deng Y, Xie Y, Liu H, Gong F (2013) Expression and significance of HMGB1, TLR4 and NF-kappaB p65 in human epidermal tumors. BMC Cancer 13:311
Weyn B, Jacob W, da Silva VD, Montironi R, Hamilton PW, Thompson D, Bartels HG, Van Daele A, Dillon K, Bartels PH (2000) Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions. Cytometry 41(2):133–138
Whitman M, Downes CP, Keeler M, Keller T, Cantley L (1988) Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332(6165):644–646
Wied GL, Bartels PH, Bibbo M, Sychra JJ (1980) Cytomorphometric markers for uterine cancer in intermediate cells. Anal Quant Cytol 2(4):257–263
Wikonkal NM, Brash DE (1999) Ultraviolet radiation induced signature mutations in photocarcinogenesis. J Investig Dermatol Symp Proc 4(1):6–10
Wilgus TA, Ross MS, Parrett ML, Oberyszyn TM (2000) Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins Other Lipid Mediat 62(4):367–384
Wilgus TA, Breza TS Jr, Tober KL, Oberyszyn TM (2004) Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors. J Invest Dermatol 122(6):1488–1494
Wolf JE Jr, Taylor JR, Tschen E, Kang S (2001) Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 40(11):709–713
Wondrak GT, Jacobson MK, Jacobson EL (2005) Identification of quenchers of photoexcited States as novel agents for skin photoprotection. J Pharmacol Exp Ther 312(2):482–491
Wood WR, Seftor EA, Lotan D, Nakajima M, Misiorowski RL, Seftor RE, Lotan R, Hendrix MJ (1990) Retinoic acid inhibits human melanoma tumor cell invasion. Anticancer Res 10(2A):423–432
Wright TI, Spencer JM, Flowers FP (2006) Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol 54(6):933–946; quiz 947-950
Wu DC, Guiha I, Goldman MP (2017) A prospective pilot clinical trial to evaluate the efficacy and safety of topical therapy with ingenol mebutate gel 0.015% for actinic keratosis on an expanded area of the chest. J Clin Aesthet Dermatol 10(8):31–36
Xu XC, Clifford JL et al (1994) Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in sit hybridization histochemistry. Diagn Mol Pathol 3(2):122–131
Xu C, Huang MT, Shen G, Yuan X, Lin W, Khor TO, Conney AH, Kong AN (2006) Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res 66(16):8293–8296
Yasuda H, Kobayashi H, Ohkawara A, Kuzumaki N (1989) Differential expression of ras oncogene products among the types of human melanomas and melanocytic nevi. J Investig Dermatol 93(1):54–59
Youl PH, Youlden DR, Baade PD (2013) Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time: implications for public health campaigns. Br J Dermatol 168(1):136–144
Zaravinos A, Kanellou P, Spandidos DA (2010) Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers. Br J Dermatol 162(2):325–331
Zhang J, Bowden GT (2012) Activation of p38 MAP kinase and JNK pathways by UVA irradiation. Photochem Photobiol Sci 11(1):54–61
Zhang H, Rosdahl I (2006) Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis. Int J Oncol 28(3):661–666
Zhang Y, Zhong S, Dong Z, Chen N, Bode AM, Ma W, Dong Z (2001) UVA induces Ser381 phosphorylation of p90RSK/MAPKAP-K1 via ERK and JNK pathways. J Biol Chem 276(18):14572–14580
Zhang YP, Chu RX, Liu H (2014) Vitamin A intake and risk of melanoma: a meta-analysis. PLoS One 9(7):e102527
Zhu M, Bowden GT (2004) Molecular mechanism(s) for UV-B irradiation-induced glutathione depletion in cultured human keratinocytes. Photochem Photobiol 80(2):191–196
Zhu M, Zhang Y, Bowden GT (2006) Involvement of mitogen-activated protein kinases and protein kinase C in regulation of antioxidant response element activity in human keratinocytes. Cancer Lett 244(2):220–228
Zhu F, Zykova TA, Kang BS, Wang Z, Ebeling MC, Abe Y, Ma WY, Bode AM, Dong Z (2007) Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells. Gastroenterology 133(1):219–231
Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE et al (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 90(9):4216–4220
Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracopoli NC (1996) Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12(1):97–99
Zykova TA, Zhu F, Lu C, Higgins L, Tatsumi Y, Abe Y, Bode AM, Dong Z (2006) Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells. Clin Cancer Res 12(23):6884–6893
Zykova TA, Zhu F, Vakorina TI, Zhang J, Higgins LA, Urusova DV, Bode AM, Dong Z (2010) T-LAK cell-originated protein kinase (TOPK) phosphorylation of Prx1 at Ser-32 prevents UVB-induced apoptosis in RPMI7951 melanoma cells through the regulation of Prx1 peroxidase activity. J Biol Chem 285(38):29138–29146
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lluria-Prevatt, M., Dickinson, S.E., Alberts, D.S. (2019). Skin Cancer Prevention. In: Alberts, D., Hess, L. (eds) Fundamentals of Cancer Prevention. Springer, Cham. https://doi.org/10.1007/978-3-030-15935-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-15935-1_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15934-4
Online ISBN: 978-3-030-15935-1
eBook Packages: MedicineMedicine (R0)